Diffuse large B-cell lymphoma (DLBCL) is a cancer of the B cells of the lymphatic system. B cells are responsible for producing antibodies, which are highly specific proteins that fight against ...
B cells are a subtype of lymphocyte. They form part of the adaptive immune response and mediate humoral immunity. B cells can produce high-affinity antibodies and generate immunological memory.
B-cell therapy (also called B-cell depletion therapy) is a treatment for people with multiple sclerosis (MS). It targets certain cells -- called B cells -- that can damage nerve fibers in your ...
In several B cell malignancies, BTK is a crucial mediator of oncogenic signalling pathways and inhibitors of this kinase have substantially improved patient outcomes. This Review discusses the ...
B-cell therapy uses drugs called monoclonal antibodies to attack white blood cells known as B cells that cause nerve damage. The FDA has approved three such drugs for MS. Ocrelizumab (Ocrevus ...
Before multiple testing correction, there were 50 products associated with either log-transformed % total, CD25+, CD69+ or TSLPR+ ILC2 cells (Supplementary Figure 2 ... and intensity of IgE antibody ...
In vivo, STK17B inhibition led to dose-dependent modulation of myosin light chain 2 phosphorylation and enhanced priming of naïve T cells, as determined by upregulation of CD69, IL-2 and interferon-γ ...
Immunoglobulin A nephropathy (IgAN) is characterized by the deposition of IgA in glomerular mesangium. Compelling results indicate possible links between neurotransmitters, intestinal mucosal IgA + B ...
According to the company, it has begun low-volume production of its initial B-sample cells, which will soon be sent to automotive partners for EV implementation testing. The decade-plus journey ...
Background: Both plasmacytoid dendritic cells (pDCs) and B cells play pivotal roles in various autoimmune diseases, such as systemic lupus erythematosus (SLE), systemic sclerosis, and rheumatoid ...
Most notably, QuantumScape revealed it has started the production of low volumes of its first B-sample cells, which are now being shipped for testing by automotive customers. Achieving this ...